226 related articles for article (PubMed ID: 23202954)
1. ABO blood group system and gastric cancer: a case-control study and meta-analysis.
Wang Z; Liu L; Ji J; Zhang J; Yan M; Zhang J; Liu B; Zhu Z; Yu Y
Int J Mol Sci; 2012 Oct; 13(10):13308-21. PubMed ID: 23202954
[TBL] [Abstract][Full Text] [Related]
2. Risk of advanced gastric precancerous lesions in Helicobacter pylori infected subjects is influenced by ABO blood group and cagA status.
Rizzato C; Kato I; Plummer M; Muñoz N; Stein A; Jan van Doorn L; Franceschi S; Canzian F
Int J Cancer; 2013 Jul; 133(2):315-22. PubMed ID: 23319424
[TBL] [Abstract][Full Text] [Related]
3. Association Between ABO Blood Groups and Helicobacter pylori Infection: A Meta-Analysis.
Chakrani Z; Robinson K; Taye B
Sci Rep; 2018 Dec; 8(1):17604. PubMed ID: 30514875
[TBL] [Abstract][Full Text] [Related]
4. Risk for gastric cancer in people with CagA positive or CagA negative Helicobacter pylori infection.
Parsonnet J; Friedman GD; Orentreich N; Vogelman H
Gut; 1997 Mar; 40(3):297-301. PubMed ID: 9135515
[TBL] [Abstract][Full Text] [Related]
5. Association of ABO Blood Groups and Risk of Gastric Cancer.
Yu H; Xu N; Li ZK; Xia H; Ren HT; Li N; Wei JB; Bao HZ
Scand J Surg; 2020 Dec; 109(4):309-313. PubMed ID: 31282314
[TBL] [Abstract][Full Text] [Related]
6. Immune response to a recombinant fragment of the CagA protein of Helicobacter pylori in blood donors and patients with gastric cancer: relation to ABO(H) blood group phenotype, stage of the disease and tumor morphology.
Klaamas K; Kurtenkov O; Covacci A; Lipping A; Wadström T
Med Microbiol Immunol; 1999 May; 187(4):227-32. PubMed ID: 10363680
[TBL] [Abstract][Full Text] [Related]
7. Effect of Helicobacter pylori Eradication and ABO Genotype on Gastric Cancer Development.
Oh S; Kim N; Kwon JW; Shin CM; Choi YJ; Lee DH; Jung HC
Helicobacter; 2016 Dec; 21(6):596-605. PubMed ID: 27191536
[TBL] [Abstract][Full Text] [Related]
8. Blood groups A and AB are associated with increased gastric cancer risk: evidence from a large genetic study and systematic review.
Mao Y; Yang W; Qi Q; Yu F; Wang T; Zhang H; Dai J; Ma H; Hu Z; Shen H; Li G; Jin G
BMC Cancer; 2019 Feb; 19(1):164. PubMed ID: 30791881
[TBL] [Abstract][Full Text] [Related]
9. ABO blood type, Lewis and Secretor genotypes, and chronic atrophic gastritis: a cross-sectional study in Japan.
Shibata A; Hamajima N; Ikehara Y; Saito T; Matsuo K; Katsuda N; Tajima K; Tatematsu M; Tominaga S
Gastric Cancer; 2003; 6(1):8-16. PubMed ID: 12673421
[TBL] [Abstract][Full Text] [Related]
10. ABO blood group and risk of pancreatic cancer: a study in Shanghai and meta-analysis.
Risch HA; Lu L; Wang J; Zhang W; Ni Q; Gao YT; Yu H
Am J Epidemiol; 2013 Jun; 177(12):1326-37. PubMed ID: 23652164
[TBL] [Abstract][Full Text] [Related]
11. ABO blood group, Helicobacter pylori seropositivity, and risk of pancreatic cancer: a case-control study.
Risch HA; Yu H; Lu L; Kidd MS
J Natl Cancer Inst; 2010 Apr; 102(7):502-5. PubMed ID: 20181960
[TBL] [Abstract][Full Text] [Related]
12. Association of gastroduodenal disease phenotype with ABO blood group and Helicobacter pylori virulence-specific serotypes.
Sharara AI; Abdul-Baki H; ElHajj I; Kreidieh N; Kfoury Baz EM
Dig Liver Dis; 2006 Nov; 38(11):829-33. PubMed ID: 16931196
[TBL] [Abstract][Full Text] [Related]
13. ABO, Lewis, secretor and non-secretor phenotypes in patients infected or uninfected by the Helicobacter pylori bacillus.
de Mattos LC; Rodrigues Cintra J; Sanches FE; Alves da Silva Rde C; Ruiz MA; Moreira HW
Sao Paulo Med J; 2002 Mar; 120(2):55-8. PubMed ID: 11994774
[TBL] [Abstract][Full Text] [Related]
14. Chemoprevention of gastric cancer development after
Sugimoto M; Murata M; Yamaoka Y
World J Gastroenterol; 2020 Apr; 26(15):1820-1840. PubMed ID: 32351296
[TBL] [Abstract][Full Text] [Related]
15. ABO genotype and the risk of gastric cancer, atrophic gastritis, and Helicobacter pylori infection.
Nakao M; Matsuo K; Ito H; Shitara K; Hosono S; Watanabe M; Ito S; Sawaki A; Iida S; Sato S; Yatabe Y; Yamao K; Ueda R; Tajima K; Hamajima N; Tanaka H
Cancer Epidemiol Biomarkers Prev; 2011 Aug; 20(8):1665-72. PubMed ID: 21680535
[TBL] [Abstract][Full Text] [Related]
16. Association Between Helicobacter pylori Eradication and Gastric Cancer Incidence: A Systematic Review and Meta-analysis.
Lee YC; Chiang TH; Chou CK; Tu YK; Liao WC; Wu MS; Graham DY
Gastroenterology; 2016 May; 150(5):1113-1124.e5. PubMed ID: 26836587
[TBL] [Abstract][Full Text] [Related]
17. [Helicobacter pylori CagA(+) infection in gastric cancer patients].
Ławniczak M; Starzyńska T
Pol Merkur Lekarski; 2002 Sep; 13(75):216-20. PubMed ID: 12474574
[TBL] [Abstract][Full Text] [Related]
18. Pancreatic cancer: Helicobacter pylori colonization, N-nitrosamine exposures, and ABO blood group.
Risch HA
Mol Carcinog; 2012 Jan; 51(1):109-18. PubMed ID: 22162235
[TBL] [Abstract][Full Text] [Related]
19. ABO blood group and esophageal carcinoma risk: from a case-control study in Chinese population to meta-analysis.
Wang W; Liu L; Wang Z; Lu X; Wei M; Lin T; Zhang Y; Jiang S; Wang Q; Cao Z; Shi M
Cancer Causes Control; 2014 Oct; 25(10):1369-77. PubMed ID: 25064033
[TBL] [Abstract][Full Text] [Related]
20. Peptic ulcer bleeding: interaction between non-steroidal anti-inflammatory drugs, Helicobacter pylori infection, and the ABO blood group system.
Kuyvenhoven JP; Veenendaal RA; Vandenbroucke JP
Scand J Gastroenterol; 1999 Nov; 34(11):1082-6. PubMed ID: 10582757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
